A 37-year-old woman ignored shifting bowel habits as IBS until a colonoscopy found a rectal tumour; specialists say rectal cancer in younger adults is rising and stress early testing and lifestyle prevention

The story begins with subtle changes that most people might shrug off: altered toilet routines, intermittent constipation, sudden urges and a persistent sensation of incomplete emptying. For 37-year-old Ashleigh, these were familiar feelings she had previously labelled as irritable bowel syndrome (IBS).
Only when she noticed blood in the toilet bowl while travelling did she seek medical attention, setting off a chain of events that ended with a colonoscopy diagnosis of a 4cm tumour in the rectum.
Initial tests, including blood work and a stool check known as a FIT test, were reassuringly clear, and doctors first suggested a recurrence of IBS.
Ashleigh persisted, partly because of a family history of stomach cancer, and in March 2026 she secured a follow-up appointment and private imaging. The invasive investigation revealed that the tumour had already spread to nearby lymph nodes, classifying the disease as stage three.
The patient journey: symptoms, tests and shock
Ashleigh had experienced alternating constipation and urgency: days without a bowel movement followed by small, frequent passages that never felt complete. These signs—together with abdominal discomfort and a small amount of bright red blood—are frequently misattributed to haemorrhoids or functional disorders. After the colonoscopy, she learned the cause was a tumour obstructing her back passage. Further staging scans confirmed local spread, which explained the more severe pattern of symptoms.
Treatment began with combined modalities: she underwent chemotherapy and targeted radiation to shrink the lesion, followed by surgical removal. That sequence—shrinking a locally advanced tumour before operating—is common for cancers that break through the bowel wall into surrounding tissue. After nearly a year of operations and adjuvant treatment, Ashleigh is currently cancer-free, though she describes ongoing anxiety about recurrence.
Why rectal cancer in younger adults is drawing alarm
Clinicians and researchers have noted a worrying trend: diagnoses of rectal cancer are increasing in people under 50, even as overall rates in older adults fall thanks to screening. Recent analyses presented by US teams highlight that deaths from rectal cancer in those under 45 are rising faster than deaths from colon cancer in the same age group. Experts warn this pattern could continue unless awareness and diagnostic practices adapt.
Some biological differences may help explain the pattern. The rectum lacks the protective outer layer called the serosa, making it easier for tumours there to invade nearby tissue and recur after treatment. Pathologists report that early-onset rectal tumours can behave more aggressively, contributing to higher rates of recurrence and mortality compared with cancers that arise higher in the colon.
Diagnosis, staging and outcomes
When bowel cancer is confined to the bowel lining, the five-year survival can be about 91 percent. That figure drops to roughly 74 percent when nearby lymph nodes are involved, and to 13 percent once distant organs are affected. Unfortunately, studies show that many younger patients arrive at diagnosis after the disease has already spread, making curative treatment more difficult.
Prevention and what patients should do
Research suggests lifestyle and diet play a significant role in risk. Nutrition studies estimate that a large proportion of bowel cancer cases are linked to modifiable factors: low-fibre diets, high consumption of red and processed meat, sugary drinks, alcohol use, smoking, obesity and physical inactivity all increase risk. The gut microbiome—the community of bacteria in the intestine—also differs in many people with early-onset disease, and dietary patterns high in ultra-processed foods and emulsifiers may be contributing.
Screening and practical advice
Campaigners and clinicians advise that anyone with worrying symptoms should press their GP for evaluation and a home FIT test, which can detect hidden blood in stool. In the UK the routine screening programme currently invites adults from age 50 every two years, but advocates argue guidelines should reflect changing epidemiology. As one patient and support groups stress: do not be told you are too young to have cancer—if symptoms persist or worsen, request further investigation.
For individuals seeking to lower their risk, experts recommend increasing intake of whole grains, fruit, vegetables, pulses and legumes to reach recommended fibre targets; reducing processed and red meat; cutting back on sugary beverages and alcohol; stopping smoking; and remaining physically active. Together with prompt symptom investigation and improved screening strategies, these steps offer practical routes to reduce personal and population risk.
Ashleigh’s message is simple and urgent: if something feels wrong, be persistent. Early testing and diagnosis can change outcomes, and awareness that rectal cancer can affect younger adults may help others avoid delayed detection.
